Nation of Georgia

NRx Pharmaceuticals Announces 2nd Quarter 2021 Financial Update

Emergency Use Authorization (EUA) Request for ZYESAMI™ (aviptadil) Pending with United States Food and Drug Administration to Treat Patients Suffering from Critical COVID-19 with Respiratory Failure Emergency Use Authorization Granted to ZYESAMI in Nation of Georgia to Treat Critical COVID-19 Patients in July; First Orders for ZYESAMI in Georgia Under Discussion NRx Pharmaceuticals Initiating Phase […]

NRx Pharmaceuticals Announces Emergency Use Authorization of ZYESAMI™ (aviptadil) in Nation of Georgia

More than One Thousand New Cases of COVID-19 Diagnosed Every Day in Georgia, With Increasing Detection of the Delta Variant Association of Georgian Physicians Unanimously Supports Regulatory Decision Training of Georgian Doctors in use of ZYESAMI™ (aviptadil) to Begin Within 24 Hours RADNOR, Pa., July 27, 2021 /PRNewswire/ — NRx Pharmaceuticals (Nasdaq: NRXP) (NRx), a clinical stage, global […]